Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Janux Therapeutics
Biotech
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Takeda taps Kim as new CEO. Kailera goes commercial with Lilly vet. Roche adds technology officer to executive team.
Darren Incorvaia
,
Zoey Becker
Jan 31, 2025 8:30am
Janux's T-cell engager makes waves, again, with new data drop
Dec 3, 2024 11:40am
Janux's shares jump 130% following T-cell engager data drop
Feb 27, 2024 10:35am
Merck-partnered Janux hires CMO as its bispecifics near clinic
Jun 4, 2021 8:05am
Janux seeks $100M IPO on preclinical promise of bispecifics
May 21, 2021 6:55am
Janux raises $56M to take safer T-cell engagers into the clinic
Mar 3, 2021 8:00am
